Page 44 - Robert Barrow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.

The price of waiting: The pandemic's secondary health crisis Plus: Life science industry applauds city's $1B commitment CMS increases Medicare payment rates for at-home vaccination Print To Welecia Magsisi, it looked like a white speck. To her doctor, it was ductal carcinoma in situ. But over the phone that day in March 2020, the day before the city would declare a state of emergency, Magsisi's breast cancer diagnosis just sounded like a bunch of medical jargon. Magsisi had been religious about getting regular mammograms. At 74, with several surgeries behind her, the Elmhurst resident knew th...

Mind Medicine (MindMed) Inc (NASDAQ: MNMD) (NEO: MMED), a biotech company focused on the field of psychedelics, formally announced this week that J.R. Rahn, ...

MindMed Announces Chief Executive Officer Transition News provided by Share this article Share this article NEW YORK, June 9, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading clinical-stage pharmaceutical company and pioneer in the field of psychedelic inspired medicines, announces that J.R. Rahn, the Company's co-founder and chief executive officer, is stepping down as chief executive officer and a director, and that its chief development officer, Robert Barrow, will assume the position of chief executive officer with immedi...

Mind Medicine Inc. (NASDAQ:MNMD), more commonly known as M...